Clinical Trial Update: Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing two once-daily antiretroviral regimens used alongside anti-tuberculosis therapy for TB/HIV coinfection; current status is not spe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Snippet

Sponsor: Tuberculosis Research Centre, India | Conditions: Tuberculosis, Human Immunodeficiency Virus Infections | Phase 3 | Status: UNKNOWN